40 Mg Irinotecan Hydrochloride Injection IP

Name: 40 Mg Irinotecan Hydrochloride Injection IP
Brand: NEETCO BIOPHARMA
Price: 699 INR
Availability: InStock

Price 699 INR/ Vial

Get a Price/Quote

MOQ : 145 Vials

40 Mg Irinotecan Hydrochloride Injection IP Specification

Salt Composition
Irinotecan Hydrochloride 40 mg/2 ml

Dosage Form
Injection

Indication
Metastatic colorectal cancer, small cell lung cancer, advanced gastric cancer (as directed by physician)

Feature
Ready to use, sterile, single-use vial

Ingredients
Irinotecan Hydrochloride Trihydrate

Application

Ph Level
Approx. 3.5 (2.5-3.9)

Physical Color/Texture
Clear, pale yellow solution

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light. Do not freeze.

Shelf Life
24 months

About 40 Mg Irinotecan Hydrochloride Injection IP

Experience the unparalleled efficacy of 40 Mg Irinotecan Hydrochloride Injection IP, now available as a new release at the lowest price in the market. This venerable antineoplastic agent is remarked for its effectiveness against metastatic colorectal cancer, small cell lung cancer, and advanced gastric cancer. Packaged in a customizable glass vial (40 mg / 2 ml), it is ready to use for intravenous infusion. Its transparent, odorless liquid guarantees solubility in water and reliable compatibility with sodium chloride or dextrose solution. Suitable strictly by prescription, this single-use vial upholds the highest standards expected by healthcare professionals and distributors.

Focused Hospital and Oncology Use

40 Mg Irinotecan Hydrochloride Injection IP is crafted specifically for hospital and oncology clinical environments, providing advanced solutions for cancer care. Its ready-to-use administration type and antineoplastic advantage facilitate swift intravenous infusion, under strict medical supervision. With prescription-only access, professionals benefit from a reliable and potent treatment option, ideal for life-threatening cancers. Enhanced by its transparent appearance and odorless nature, this sterile solution is well-suited for specialized medical settings.

Global Shipment and Quality Assurance

40 Mg Irinotecan Hydrochloride Injection IP is exported globally through reliable FOB ports in India, meeting rigorous certification standards. Exporters and distributors appreciate the secure glass vial packaging, ensuring product integrity during shipment. Detailed labeling and innovative packaging solutions uphold safety across the export market. Attractive sale prices make it a competitive option for international buyers seeking quality, certified products, making it a trusted choice among hospital and clinic suppliers worldwide.

FAQ's of 40 Mg Irinotecan Hydrochloride Injection IP:

Q: How is 40 Mg Irinotecan Hydrochloride Injection IP administered?

A: This injection is administered by intravenous infusion, typically diluted with 0.9% sodium chloride or 5% dextrose solution and should only be given by qualified healthcare professionals.

Q: What are the main advantages of using this injection?

A: The main advantage is its proven effectiveness in treating metastatic colorectal cancer, small cell lung cancer, and advanced gastric cancer. The product is ready to use, comes in a sterile, single-use vial, and is supported by a venerable track record in clinical oncology.

Q: When should Irinotecan Hydrochloride Injection not be used?

A: This injection is contraindicated in patients known to have hypersensitivity to irinotecan or other excipients in the formulation. Always consult a physician before use.

Q: Where is 40 Mg Irinotecan Hydrochloride Injection IP available for export?

A: It is available for shipment to various international markets, distributed from reliable FOB ports in India. Packaging and certification comply with global export standards.